Page 2 - Thinprep System News Today

Hologic (NASDAQ:HOLX – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 4.020-4.120 for the period, compared to the consensus estimate of 4.030. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion. Hologic also updated […]

Hologic (NASDAQ:HOLX – Get Free Report) updated its third quarter 2024 earnings guidance on Friday. The company provided EPS guidance of 0.980-1.050 for the period, compared to the consensus EPS estimate of 1.020. The company issued revenue guidance of $992.5 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Hologic also updated its […]

Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 4.020-4.120 for the period, compared to the consensus earnings per share estimate of 4.030. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate […]

Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 4.020-4.120 for the period, compared to the consensus estimate of 4.030. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 […]

Hologic, Inc. (NASDAQ:HOLX – Free Report) – Investment analysts at William Blair lifted their FY2024 earnings per share estimates for Hologic in a report released on Friday, May 3rd. William Blair analyst A. Brackmann now anticipates that the medical equipment provider will earn $4.07 per share for the year, up from their prior estimate of […]

Hologic (NASDAQ:HOLX – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $4.02-$4.12 for the period, compared to the consensus estimate of $4.03. The company issued revenue guidance of $4.00-$4.05 billion, compared to the consensus revenue estimate of $4.03 billion. Hologic also updated its Q3 […]

Hologic (NASDAQ:HOLX – Get Free Report) had its price objective increased by stock analysts at JPMorgan Chase & Co. from $85.00 to $91.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. JPMorgan Chase & Co.‘s price objective points to a […]

Hologic (NASDAQ:HOLX – Get Free Report) released its earnings results on Thursday. The medical equipment provider reported $1.03 EPS for the quarter, topping the consensus estimate of $0.98 by $0.05, Briefing.com reports. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1 billion. Hologic had a net margin […]

Eagle Ridge Investment Management decreased its holdings in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 0.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 183,747 shares of the medical equipment provider’s stock after selling 705 shares during the period. Hologic comprises approximately 1.3% of Eagle Ridge Investment Management’s holdings, making the […]

Eagle Ridge Investment Management lowered its position in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 183,747 shares of the medical equipment provider’s stock after selling 705 shares during the period. […]